Independent · evidence-based · non-judgmentalDraft · pending medical review
Not yet medically reviewed — information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Cannabinoid / HHC
Cannabinoid

HHC

(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol

HHC (hexahydrocannabinol) is a hydrogenated cannabinoid with THC-like intoxicating effects, sold in hemp-derived vapes and edibles. Its safety is poorly studied, product quality is inconsistent, and the 2025 federal hemp law effective November 12, 2026 is expected to make most HHC products federally illegal.

Overview

HHC (hexahydrocannabinol) is a hydrogenated form of THC found in only trace amounts in cannabis, so commercial HHC is manufactured, typically from hemp-derived cannabinoids. It produces a THC-like intoxication and became popular as a hemp-derived product after 2018, sold in vapes, gummies, and other formats. It is one of several novel cannabinoids marketed as legal alternatives to marijuana.

Source: peer-reviewed literature (NIH/PMC); Congress.gov (CRS)

Chemistry & mechanism of action

HHC activates the CB1 cannabinoid receptor, the same target as delta-9 THC, which is why it is intoxicating; its effects are broadly THC-like. Commercial HHC is a mixture of two closely related forms that differ in how strongly they bind the receptor. Because it is manufactured by hydrogenating cannabinoids, finished products can contain catalysts, by-products, and residual chemicals from that process.

Source: peer-reviewed literature (NIH/PMC)

Effects

Effects are described as similar to a THC high — relaxation, euphoria, altered perception, increased appetite — with the usual dry mouth, red eyes, and impaired coordination. Users often describe it as somewhere between delta-8 and delta-9 in intensity. As with other poorly dosed hemp cannabinoid products, higher amounts can bring anxiety, paranoia, and rapid heart rate.

Source: peer-reviewed literature (NIH/PMC)

Risks & harms

HHC carries THC-like acute risks — anxiety, paranoia, rapid heart rate, impaired coordination, and over-intoxication at higher doses, especially with edibles — layered on top of a near-total absence of human safety research, so its longer-term and higher-dose risks are essentially unknown. Because it is chemically manufactured from other cannabinoids, products can contain hydrogenation catalysts, residual solvents, by-products, and unlabeled amounts of other cannabinoids, and independent testing repeatedly finds inconsistent and mislabeled potency. Candy-like edibles pose a serious accidental-poisoning risk to children. As with all these products, content and purity cannot be assumed. Keep away from children; if a child ingests a product, or anyone experiences severe distress, chest pain, or cannot be roused, call 911, and Poison Control at 1-800-222-1222 can advise. This page has not yet been medically reviewed.

Source: peer-reviewed literature (NIH/PMC); FDA; Congress.gov (CRS)

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.

With cannabis, anxiety or a racing heart usually pass with time. Sit somewhere calm, sip water, and rest — strong edibles in particular can take hours to ease.

Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown — pending review”

Identity

IUPAC name
(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-olPubChem PUG-REST · retrieved 2026-06-18
SMILES
CCCCCC1=CC(=C2[C@@H]3CC(CC[C@H]3C(OC2=C1)(C)C)C)OPubChem PUG-REST · retrieved 2026-06-18
InChIKey
XKRHRBJLCLXSGE-VNCLPFQGSA-NPubChem PUG-REST · retrieved 2026-06-18
Synonyms / aliases
Hexahydrocannabinol, XKRHRBJLCLXSGE-UHFFFAOYSA-NPubChem PUG-REST + seed aliases · retrieved 2026-06-18

Composition

Composition
N/A — single compound (see Identity)

Physical / pill characteristics

Dosage form
Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
Route
Unknown — pending review
Shape
Unknown — pending review
Color
Unknown — pending review
Imprint
Unknown — pending review
Score
Unknown — pending review

Scheduling & legal status

US schedule
Unknown — pending review
International
See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA · retrieved 2026-06-18

Effects

Effects
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Risks

Risks
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Interactions

Interactions
Unknown — pending review

Dosage

Pending medical reviewer

Sources

← Back to the drug index